Loading…

The resuscitative endovascular balloon occlusion of aorta (REBOA) device—what radiologists need to know

Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a novel device approved by the Food and Drug administration (FDA) in 2017 as an alternative to resuscitative emergent thoracotomy (RET). Due to advancements in placement of REBOA, including newly validated placement using anatomic...

Full description

Saved in:
Bibliographic Details
Published in:Emergency radiology 2019-12, Vol.26 (6), p.691-694
Main Authors: Arndt, Linzi, Mir, Danial, Nguyen, Johnathan, Nezami, Nariman, Dariushnia, Sean R, Findeiss, Laura K., Prater, Adam, West, Derek L., Majdalany, Bill S., Kokabi, Nima
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a novel device approved by the Food and Drug administration (FDA) in 2017 as an alternative to resuscitative emergent thoracotomy (RET). Due to advancements in placement of REBOA, including newly validated placement using anatomic landmarks, REBOA is now widely used by interventional radiologists and emergency physicians in acute subdiaphragmatic hemorrhage. Increased use of REBOA necessitates that radiologists are familiar with verification of proper REBOA placement to minimize complications. This review describes the REBOA device, indications, placement, and complications, summarizing the current available literature.
ISSN:1070-3004
1438-1435
DOI:10.1007/s10140-019-01724-w